Area of research
Oncology · Analytical Chemistry
Research interest
Research focused on PI3K/AKT/mTOR pathway and Anoikis, with related work in Protein kinase B, Cancer research, Fatty liver. Notable publications include 'The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma', 'Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China', and 'A novel deacetylase inhibitor KLX suppresses liver fibrosis by deacetylating PPARγ through promoting ubiquitination-mediated HDAC1 degradation'.
A novel deacetylase inhibitor KLX suppresses liver fibrosis by deacetylating PPARγ through promoting ubiquitination-mediated HDAC1 degradation
Nephronectin (NPNT) is a Crucial Determinant of Idiopathic Pulmonary Fibrosis: Modulating Cellular Senescence via the ITGA3/YAP1 Signaling Axis
Organelle interplay in cardiovascular diseases: Mechanisms, pathogenesis, and therapeutic perspectives
RBMS1 orchestrates cardiac hypertrophy by facilitating CTTN splice-switching and sarcomere dynamics
The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma
Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translation
Dedicator of cytokinesis protein 2 activates the epithelial–mesenchymal transition in renal fibrosis through the Rac1/PI3K/AKT pathway
Adipose mesenchymal stem cell-derived extracellular vesicles alleviate renal fibrosis by reducing epithelial-mesenchymal transition via the FOXS1/Wnt/β-catenin signaling pathway